Target intelligence / Profile preview

Conserved oligomeric Golgi complex subunit 5 (COG5)

Target
COG5
Molecular classification
Intracellular trafficking complex protein, Golgi apparatus protein, Vesicle tethering complex (CATCHR family)
01

Overview

Conserved oligomeric Golgi complex subunit 5 (COG5) is a component of the COG complex, an eight-protein assembly crucial for maintaining Golgi apparatus structure and mediating protein and lipid glycosylation. COG5 is centrally involved in the retrograde transport of vesicles within the Golgi apparatus, particularly recycling glycosylation enzymes and ensuring proper protein modification and sorting. It forms part of the lobe B subcomplex (with COG6, COG7, COG8), adopting a CATCHR (Complexes Associated with Tethering Containing Helical Rods) fold that mediates protein-protein interactions vital for vesicle tethering. Mutations in COG5 cause congenital disorders of glycosylation by disrupting Golgi trafficking and glycan processing, leading to developmental, neurological, and multisystem disease[1][2][3][4]. There are currently no known drugs targeting COG5; the gene and its protein product function as an essential vesicle trafficking scaffold rather than a conventional therapeutic target.

Other names
Component of oligomeric Golgi complex 5GOLTC1GTC90COG complex subunit 5GTC-9013S Golgi transport complex 90 kDa subunitGolgi transport complex 1CDG2IConserved oligomeric Golgi complex protein 5
02

Biological functions

Protein glycosylationRetrograde vesicle transport within GolgiVesicle tethering and dockingIntracellular protein trafficking
03

Disease associations

Congenital disorders of glycosylation (specifically COG5-congenital disorder of glycosylation, also called COG5-CDG or CDG2I)Other (due to broad effects on protein glycosylation and potential multisystem involvement)
04

Safety considerations

Broad impact on cell function if targeted, as glycosylation is essential for many proteinsDisruption leads to multisystem disease phenotypes
05

Biomarkers

Abnormal serum glycoprotein glycosylation (observed in COG5-CDG)COG5 gene mutation status (for diagnosis)

Beyond the preview

Go deeper on Conserved oligomeric Golgi complex subunit 5 (COG5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Conserved oligomeric Golgi complex subunit 5 (COG5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call